These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11905804)

  • 1. Cancer gene therapy: fringe or cutting edge?
    McCormick F
    Nat Rev Cancer; 2001 Nov; 1(2):130-41. PubMed ID: 11905804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy of tumors, state of the art and prospects].
    Lollini PL
    Pathologica; 2001 Dec; 93(6):625-30. PubMed ID: 11785112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of intratumoral gene therapy.
    Akporiaye ET; Hersh E
    Curr Opin Mol Ther; 1999 Aug; 1(4):443-53. PubMed ID: 11713758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.
    Green NK; McNeish IA; Doshi R; Searle PF; Kerr DJ; Young LS
    Int J Cancer; 2003 Mar; 104(1):104-12. PubMed ID: 12532426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for ovarian cancer.
    Coukos G; Rubin SC
    Oncology (Williston Park); 2001 Sep; 15(9):1197-204, 1207; discussion 1207-8. PubMed ID: 11589066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to cancer gene therapy.
    Cusack JC; Tanabe KK
    Surg Oncol Clin N Am; 2002 Jul; 11(3):497-519, v. PubMed ID: 12487054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus gene therapy for ovarian cancer.
    Russell W
    J Natl Cancer Inst; 2002 May; 94(10):706-7. PubMed ID: 12011212
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
    Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases.
    Pruschy M; Rocha S; Zaugg K; Tenzer A; Hess C; Fisher DE; Glanzmann C; Bodis S
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):561-7. PubMed ID: 11173155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury.
    Hedley D; Ogilvie L; Springer C
    Nat Rev Cancer; 2007 Nov; 7(11):870-9. PubMed ID: 17943135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining gene and immunotherapy for prostate cancer.
    Young JG; Green NK; Mautner V; Searle PF; Young LS; James ND
    Prostate Cancer Prostatic Dis; 2008; 11(2):187-93. PubMed ID: 17726452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-peritoneal administration of genetic therapies: promises and pitfalls.
    Evans TR; Keith WN
    Minerva Ginecol; 2004 Dec; 56(6):529-38. PubMed ID: 15729205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeting of cancer: telomeres as targets.
    Hodes R
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7649-51. PubMed ID: 11438716
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral vectors for gene-directed enzyme prodrug therapy.
    Schepelmann S; Springer CJ
    Curr Gene Ther; 2006 Dec; 6(6):647-70. PubMed ID: 17168697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
    Hermiston TW; Kuhn I
    Cancer Gene Ther; 2002 Dec; 9(12):1022-35. PubMed ID: 12522441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication-defective bovine adenovirus type 3 as an expression vector.
    Reddy PS; Idamakanti N; Chen Y; Whale T; Babiuk LA; Mehtali M; Tikoo SK
    J Virol; 1999 Nov; 73(11):9137-44. PubMed ID: 10516020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.